FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT Gottlieb: Science Contributing to ‘Inflection Point in Medicine
12/07/2017
 
 
TXT Sen. Warren Seeks $5B Funding/Research Boost for FDA and NIH
12/08/2017
 
 
TXT EU Vow to End Dental Amalgam Use by 2022
12/05/2017
 
 
TXT WLF Urges FDA to Replace Guidances with Rulemaking
12/08/2017
 
 
TXT Bayer Rebuts DeLauro Complaint on Essure Study
12/07/2017
 
 
TXT Glenmark Pharmaceuticals FDA-483 Released
12/06/2017
 
 
TXT SCOTUS Wants Government’s View on Fosamax Case
12/06/2017
 
 
TXT FDA Unveils Predictive Toxicology Roadmap
12/06/2017
 
 
TXT MDR, QS Violations at Hand Biomechanics
12/05/2017
 
 
TXT FDA Again Pushing Uniform National Regulation: Attorney
12/05/2017
 
 
TXT FDA Guidance on 3-D Printing Plans for Future Innovations
12/04/2017
 
 
TXT Product Approval Summaries
12/10/2017
 
 
TXT Since Our Last Issue ...
12/10/2017
 
 
TXT Latest Federal Register Notices
12/10/2017
 
 
TXT Mylan Petitions FDA for Strict Bioequivalence on Advair Generics
12/08/2017
 
 
TXT Avanir Paid Disciplined Doctors to Promote Nudexta: CNN
12/07/2017
 
 
TXT Drug Spending Increase Lower than Last 2 Years: Report
12/07/2017
 
 
TXT FDA Expands Digital Health Efforts: Gottlieb
12/07/2017
 
 
TXT Duke Launches Real-World Evidence Collaborative
12/07/2017
 
 
TXT FDA Urges Primus Pharma to Recall Suspect Product
12/07/2017
 
 
TXT Most Post-Approval Studies ‘On Track’: Stein
12/07/2017
 
 
TXT Senator Manchin Seeks 3 Opioid Policy Changes
12/07/2017
 
 
TXT Key Changes in Final UDI Guidance
12/06/2017
 
 
TXT Latest FDA Warning Letters
12/05/2017
 
 
TXT GCMP Issues at Hangzhou Facecare Cosmetics
12/05/2017
 
 
TXT China Made Alcohol Prep Pads Recalled
12/05/2017
 
 
TXT General, Specific Comments on Analytical Similarity Guidance
12/05/2017
 
 
TXT Don’t Approve Evolus Neurotoxin BLA: Medytox
12/05/2017
 
 
TXT Breakthrough, Fast Track Programs Cut Approval Times: Study
12/05/2017
 
 
TXT Draft Guide on Grandfathering Drugs Sans Product Identifiers
11/27/2017
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving